Ixamib 3.0mg cap (Ixazomib Capsule) 3.0mg

Ixamib 3.0mg cap is a prescription medication used for cancer treatment support. It contains ixazomib, a proteasome inhibitor, available as 3.0mg capsules. This drug is prescribed under medical supervision for specific conditions. Always follow healthcare provider guidance when using this medication.

Strength

3.0mg

Manufacturer / TM Owner

Azista Bhutan Healthcare Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ixamib 3.0mg cap is used in combination with other medications to treat certain types of cancer, such as multiple myeloma. It belongs to a class of drugs known as proteasome inhibitors, which help slow or stop the growth of cancer cells. Patients often ask, 'what is ixazomib used for' or 'ixamib 3.0mg cap uses' to understand its role in treatment plans.

Side Effects

Common effects of Ixamib 3.0mg cap may include nausea, fatigue, or reduced blood cell counts. Some users report digestive discomfort or skin rashes. These effects vary and are typically monitored by healthcare professionals during treatment.

Precautions & Warnings

Store Ixamib 3.0mg cap at room temperature, away from moisture and heat. Keep out of reach of children and pets. Handle with care to avoid contamination. Follow all handling instructions provided by your pharmacist or healthcare provider.

Avoid Interactions

Ixamib 3.0mg cap may interact with certain medications, including strong CYP3A inhibitors or inducers. Alcohol and grapefruit products may also affect its action. Always inform your doctor about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

Ixazomib is used to treat certain types of cancer, such as multiple myeloma, in combination with other medications.

Store the capsules at room temperature, away from moisture and heat, and keep them out of reach of children.

Consult your healthcare provider before taking Ixamib with other medications to avoid potential interactions.

Common side effects may include nausea, fatigue, or reduced blood cell counts, which should be monitored by a healthcare professional.

No, Ixamib 3.0mg cap is a prescription medication and requires medical supervision for use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.